课题基金 / 基金详情

The "predicting Short-term Adverse cardiovasculaR outcomes in preeclampsiA using BIomarkers" (SARABI) Pilot Study

The "predicting Short-term Adverse cardiovasculaR outcomes in preeclampsiA using BIomarkers" (SARABI) Pilot Study
“使用生物标志物预测先兆子痫的短期不良心血管结果”(SARABI) 试点研究
批准号：
461649
负责人：
Malham Isabelle
金额：
$29.26万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=461649&lang=en
关键词：
Cardio-Obstetrics Hypertension Preeclampsia Severe Maternal Morbidity

项目摘要

项目成果

Malham Isabelle的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Preeclampsia is a hypertensive disorder affecting 3-5% of pregnancies. It is defined by high blood pressure after 20 weeks of pregnancy in combination with problems of the kidneys, brain, heart, lungs, liver, blood, or placenta. Preeclampsia is a strong r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-creating knowledge mobilization activities to address pregnancy-related near-miss events and deaths in Canada
The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study
海外基金